We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Merck Logo


Merck is a science and technology company operating across healthcare, life science and performance materials. Their tools, services and digital platform make research simpler and more exact, helping to deliver breakthroughs more quickly.

Latest Merck Content

The Pistoia Alliance logo
Product News

Pistoia Alliance Launches Pharma Innovation Council and Appoints New Chief Portfolio Officer

The Pistoia Alliance has launched the Pistoia Alliance Pharma Innovation Council. The Council will seed ideas for new pre-competitive projects aligned with the Alliance’s strategic themes: Emerging sciences and Technology, Improving the Efficiency and Effectiveness of R&D and Empowering the Patient.
Two hands holding jigsaw pieces representing a partnership.
Product News

Personalis and Moderna Sign New Agreement To Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials

The platform will be used to sequence genomic information from a patient’s tumor sample to identify the unique genetic mutations that are most likely to generate a tailored antitumor response.
DNA double helix on a black background, showing a double-stranded break in the DNA.
Industry Insight

New Approaches for Cancer Therapies: Targeting the DNA Damage Response

We speak with Dr. Niall Martin, CEO of Artios Pharma, to learn more about the development of drugs to target the DNA damage response pathway in cancer.
Dr Paul Brooks, CEO, CN Bio
Product News

CN Bio Appoints Dr Paul Brooks as Chief Executive Officer

CN Bio has announced the appointment of Dr Paul Brooks, formerly the Company’s Chief Business Officer, to the position of CEO with immediate effect.
Pills in different sizes, shapes and colors.

Melanoma Clinical Trial Reveals Success of Drug Combination

A combination of a common immunotherapy drug with all-trans retinoic acid, a chemotherapeutic, has shown promise in clinical trials.
mRNA Cancer Vaccine Improves Survival Rates in Melanoma content piece image

mRNA Cancer Vaccine Improves Survival Rates in Melanoma

A new personalized cancer vaccine has demonstrated efficacy against melanoma in a Phase IIb clinical trial.
An electron microscopic image of the 1976 isolate of Ebola virus.

Ebola Vaccine Regimens Deemed Safe

Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups.
Attendees of Lab Innovations 2021 walking past exhibition booths.
Product News

Driving Sustainability in the Lab Industry

The UK’s largest annual trade show for the lab industry, Lab Innovations will focus on the theme of sustainability at this year’s show, taking place on November 2 and 3 at the NEC, Birmingham.
Light Scattering Methods for Better Developability Assessment of Biologic Therapeutics content piece image
App Note / Case Study

Light Scattering Methods for Better Developability Assessment of Biologic Therapeutics

Read how scientists at Merck KGaA use light scattering measurements to predict how formulations will behave at clinically relevant concentrations and find the optimal formulation buffer for their biologics candidates.
A New Method for Testing Protein-Based Drugs content piece image

A New Method for Testing Protein-Based Drugs

Rsearchers have unveiled a new lab technique they say represents a “paradigm shift” in how pharmaceutical laboratories test and produce new protein-based drugs, such as therapeutic monoclonal antibodies being developed to treat a variety of diseases, from cancers to infectious diseases.